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Abstract
The paper gives rather a broad overview on the development of the use of antibiotics and chemotherapeutics from there 
very beginning until today. The paper deals with scientific facts known in the medical and veterinary community, but also 
with speculations and “gut-feeling” demands of activist groups that criticise e.g. intensive animal production procedures 
as “factory farming”. The discussions about the need to curb the problem of bacterial resistance and the various attempts 
to regulate the use of antibiotics in food animals are summarised, and the paper underlines that veterinarians carry the 
major responsibility for the most desirable use of antimicrobial substances, the “prudent use of antibiotics”, where, when 
antimicrobials have to be applied, the application leads to the highest possible health effect and the lowest possible resist-
ance in the bacteria accompany and/or threaten humans and animals. The paper, however, also argues that 
meeting demand for reducing the overall amount of antibiotics used in food animals needs a different approach: instead 
of only asking veterinarians to refrain from an overuse (especially the routine use) of antibiotics mainly in pigs and poultry, 
a concerted action of the farming community together with their consulting veterinarians is necessary with the clear target 
to significantly increase the health of the food animal populations by optimising the herd and flock health management, 
which automatically will result in a measurable reduction of reliance of the food animal production on antibiotics. Conclud-
ing, the paper speculates that there will be no significant reduction in the amount of antimicrobials used in food animals, 
unless farmers and veterinarians find new approaches to investing money in the health of herds and flocks, i.e. paying 
veterinary services for maintaining the animals’ health rather than for curing their diseases.
THE breakthrough in battling bacterial disease
The development of sulphonamides by Gerhard Domagk and the discovery of penicillin by Alexander Fleming have been 
celebrated as milestones in mankind’s attempts to reduce premature death and pain and suffering due to disease. There 
are no hard data about the percentage of the causes of death prior to the establishment of any state health system, but it 
can be argued that infectious diseases have been the major death causes for thousands of years. This is definitively true 
for the centuries when, due to an increase of human populations moving and commingling throughout Europa and to the 
start of urbanisation without any coordinated sanitation, the main epidemics that killed millions of people were Plague, 
Cholera and Typhoid. These bacterial epidemics had an exponentially higher death toll than any viral epidemic. There 
are no hard data to prove of disprove, if not many a million of the many millions of deaths due to the 1918 Hongkong 
Flu epidemic were due to secondary bacterial infections that maybe dramatically increased the number of fatalities. There 
are speculations that the number of people that lost their lives in wars due to the direct effect of a weapon is manifold 
smaller than the number of wounded people that later died due to the bacterial infections caused by their being wounded.
In other words the fact that mankind suddenly was able to cure bacterial infections and to fight life-threatening bacteria 
(chemotherapeutics/ antibiotics and disinfectants) was celebrated as man’s victory over infectious disease.
The triumphal march, disillusionment and finally a realistic view
Whereas in the early years of the availability of sulphonamides and antibiotics, only life-threatening infections of humans 
were treated, but soon more and more application areas were added: less harmful infections in humans, bacterial 
diseases in animals, more and more non-fatal diseases in humans up to the treatment of just “annoying” infections such as 
common colds, growth promotion (“non-therapeutic use”) in food animals, and the routine prophylactic and “metaphylac-
tic” use in large scale food animal production units. This development of expanding the use of antimicrobial substances 
would have remained being welcomed and undisputed, if there were not the phenomenon of acquired bacterial 
resistance in bacteria species that naturally are highly sensible to certain antimicrobial substances. When the first 
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bial substances and nothing about the molecular mechanisms that determine the inefficiency of the so far fully potent drugs. 
It took some decades of finger-pointing (especially between the medical and veterinary profession) and learning that there 
has to be a hierarchy in the use of antimicrobial substances before the development of a realistic view on how to maintain 
the “sharpness of this valuable tool against bacterial disease” especially for those antimicrobial groups that are of critical 
importance in human medicine. 
The initial hope that the threat of bacterial pathogens to human health had been banned the by the use of antimicrobial 
substances was shattered. However, exactly this experience led, to increased research activities into the mechanisms of 
the development of bacterial resistance through either the acquisition of a plasmid or a single point mutation. The major 
step in developing a general understanding that maintaining the efficacy of whichever antimicrobial is the WAY we use 
them in human and veterinary medicine was that it was comprehended that ANY use of ANY antimicrobial compound 
leads to a selection pressure in the targeted (and the simultaneously occurring) bacterial populations towards bacteria that 
are less vulnerable (sensitive) and withstand the bactericidal or bacteriostatic mechanisms, and that it is necessary to 
develop intelligent strategies to minimise the MAGNITUDE of the selection pressure. This understanding was also 
supported by the relatively late realisation that bacterial populations are by far faster to adapt to antimicrobial compounds 
than humans are able to find or develop and produce new compounds.
Strategies to curb bacterial resistance
The most important step in guiding medical and veterinary users of antimicrobial substances as treatment of bacterial 
infections was the development of the concept of the “prudent use of antibiotics”, which is defined as applying antimicro-
bials in a way that leads to the highest possible health effect in humans or animals and to the lowest possible resistance 
in the bacteria that are exposed to the compound. WHO and FAO, but also many national medical and veterinary 
associations, chambers and international organisations such as FVE for veterinary medicine have issued guidelines on the 
prudent use of antibiotics. They all may differ in some details, but the following major basic principles are common for all 
prudent-use-guidelines: 
- use only licensed antimicrobials only as much and as long as necessary and as little and as short as possible; 
- select targeted antimicrobials according to the natural sensitivity of the identified bacterial species;
-  use the chosen antimicrobial compound in the highest possible dosage and over the shortest possible period of time, 
which is yet long enough to minimise the selection of resistant bacterial strains; 
-  base this decision as often as possible on laboratory results on the actual sensitivity (clinical breakpoint) of the disease-
causing bacterial strains;
- refrain from using broad-band antibiotics wherever possible;
-  refrain from using antimicrobial groups of critical importance for human medicine in non-life-threatening bacterial 
infections of humans and in veterinary medicine.  
These guidelines for the prudent use of antibiotics are nowadays broadly accepted in the medical and veterinary 
professions and they have definitively led to a higher degree of compliance with practices that are known to reduce the 
development of bacterial resistance (including a better supervision of the application of antibiotics in feed and water by 
the farmers!). 
However, to which degree the magnitude of bacterial resistance in veterinary medicine has been influenced by the 
principles of the prudent use of antibiotics is more or less unknown, since the existing data on bacterial resistance are 
hardly comparable not only from country to country, but also over time. The decision of the EU to command the EFSA 
(based on Article 33 of the Reg. [EC] 178/2002) to carry out a standardised collection and analysis of data on 
zoonoses, antimicrobial resistance and food-borne outbreaks, is a major precondition for a meaningful measurement of 
the development of bacterial resistance specially in bacteria that cause zoonoses and food-borne diseases in humans. 
Unfortunately, the period of time, which EFSA needs to harmonise this data collection and to demonstrate make sound 
decisions on which measures which country needs to take, is longer than we need quiet down the still growing criticism 
with the use of antibiotics in food animals.
Measures in animal production beyond the “prudent use”
The still growing societal concerns expressed by public health authorities and organisations such as WHO, CDC and 
EFSA, is nowadays increasingly taken up by NGO’s targeting modern animal production systems. And their “cause” is, 
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producing animals (laMRSA), and ESBL. Only one quote from the Global Edition of the New York Times (March 23, 
2011) illustrates the general perception of the deficiencies in the use of antibiotics in general, but also in food producing 
animals: “…But antibiotics are frequently misused – overprescribed or incorrectly taken by patients, and recklessly fed to 
farm animals”.  
As responsible researchers used to asking for sound data-based analyses we tend to ignore statements that lack reason-
able evidence (show me the data that prove that the use of … has led to…). However, in the light of our consensus on 
the fact that ANY use of antimicrobial substances leads to bacterial resistance as well in the targeted bacterial strains as 
in all other bacteria that are exposed to the antimicrobial in question, we need to agree on the demand for reducing to-
day’s amount of antibiotics and chemotherapeutics used in general in food animals as much as possible as long as we 
achieve the necessary health effect in case of acute infections. 
But here we need to accept that the rules for the prudent use of antibiotics are NOT able address the reliance of animal 
production on the routine use of antimicrobials. If bacterial disease is occurring in any animal population, it is the ethical 
duty of veterinarians to apply antimicrobial substances, of course following the rules of their prudent use. It has been 
ignored for too long that field veterinarians, although society expects them to consult farmers to optimise their 
husbandry systems and their management skills regarding animal health, have not the legal “power” to enforce their 
recommendations.
Especially in countries, where veterinarians are the only source of drugs for the farmers, it is widely believed that this fact 
is the major reason for a comparatively high consumption of antimicrobial substances in food animals. At first glance this 
seems to be supported by the relatively low amount of antibiotics (measured in mg/kg meat produced) in Norway, 
Sweden and Finland. However, Austria has the same low consumption, and it should not be forgotten, that the Scandina-
vian countries have a long tradition of animal health schemes including long-standing and successful Salmonella monitor-
ing and reduction programmes. And, the wide range from about 50 mg/kg meat produced in Ireland and Denmark up 
to more than 250 mg/kg in Greece and the USA shows that there must be other factors that much more influence the 
quantities of antimicrobial substances that are used in food animal populations than just the way how farmers are supplied 
with drugs.
Not only well-proven experiences of every single veterinary practitioner, but also a growing number of scientific papers 
on the huge variability of the amount of antimicrobials used in food animals at the herd and flock level, tell us that the 
animal-health awareness of farmers and their management skills determine the health status of the herd or flock in question, 
which in turn, determines the necessary amount of antibiotics applied or prescribed by the veterinarian. 
The results of our research projects on testing the so-called “Animal Treatment Index” and the Danish comparison of the use 
of antimicrobials per pig herd by measuring the Animal Daily Doses (ADD) prove that there is a need to revise the main 
stream attempts to force veterinarians to use less antimicrobials (which is twisting the arm of the wrong people) into first 
measuring the amount of antibiotics at farm level. Using a benchmarking system such the “Yellow Card Initiative”, 
introduced last year in Denmark by the Danish Veterinary and Food Administration, will lead to concerted actions to meas-
urably increase the health of the food animal populations, which “automatically” will lead to a reduction of routinely 
administered antimicrobials in food animals.
  
